Ding Ren Shen

2.2k total citations
35 papers, 1.1k citations indexed

About

Ding Ren Shen is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Ding Ren Shen has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 8 papers in Organic Chemistry and 7 papers in Oncology. Recurrent topics in Ding Ren Shen's work include Melanoma and MAPK Pathways (9 papers), Advanced biosensing and bioanalysis techniques (8 papers) and Advanced Nanomaterials in Catalysis (5 papers). Ding Ren Shen is often cited by papers focused on Melanoma and MAPK Pathways (9 papers), Advanced biosensing and bioanalysis techniques (8 papers) and Advanced Nanomaterials in Catalysis (5 papers). Ding Ren Shen collaborates with scholars based in United States, China and Russia. Ding Ren Shen's co-authors include Jeremy A. Squire, Rosanna Weksberg, Qiyi He, Xiping Cui, Joel C. Barrish, Yingshan Chen, Gary L. Schieven, Arthur M. Doweyko, Sidney Pitt and Suqing Zhao and has published in prestigious journals such as Nature Genetics, Analytical Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

Ding Ren Shen

35 papers receiving 1.1k citations

Peers

Ding Ren Shen
R. Marshall Pope United States
Jeffrey P. Krise United States
Vishal Agrawal United States
Haim Barr Israel
Ian S. Goldlust United States
Ding Ren Shen
Citations per year, relative to Ding Ren Shen Ding Ren Shen (= 1×) peers Rosaria Benedetti

Countries citing papers authored by Ding Ren Shen

Since Specialization
Citations

This map shows the geographic impact of Ding Ren Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ding Ren Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ding Ren Shen more than expected).

Fields of papers citing papers by Ding Ren Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ding Ren Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ding Ren Shen. The network helps show where Ding Ren Shen may publish in the future.

Co-authorship network of co-authors of Ding Ren Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Ding Ren Shen. A scholar is included among the top collaborators of Ding Ren Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ding Ren Shen. Ding Ren Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shen, Ding Ren, Wei Hu, Suqing Zhao, & Chuanbin Mao. (2021). Rapid Naked-Eye Detection of a Liver Disease Biomarker by Discovering Its Monoclonal Antibody to Functionalize Engineered Red-Colored Bacteria Probes. ACS Omega. 6(47). 32005–32010. 2 indexed citations
2.
Cui, Xiping, Qiyi He, Huiyi Yang, et al.. (2021). Development of enzyme-free single-step immunoassays for glycocholic acid based on palladium nanoparticle-mediated signal generation. Analytical and Bioanalytical Chemistry. 413(23). 5733–5742. 7 indexed citations
3.
He, Qiyi, Huiyi Yang, Xiping Cui, et al.. (2020). Lateral Flow Immunosensor for Ferritin Based on Dual Signal-Amplified Strategy by Rhodium Nanoparticles. ACS Applied Bio Materials. 3(12). 8849–8856. 15 indexed citations
4.
Yang, Huiyi, Qiyi He, Yingshan Chen, et al.. (2020). Platinum nanoflowers with peroxidase-like property in a dual immunoassay for dehydroepiandrosterone. Microchimica Acta. 187(11). 592–592. 29 indexed citations
5.
Zhang, Chunguo, Yingying Zhong, Qiyi He, et al.. (2020). Positively Charged Nanogold Combined with Expanded Mesoporous Silica-Based Immunoassay for the Detection of Avermectin. Food Analytical Methods. 13(5). 1129–1137. 7 indexed citations
6.
He, Qiyi, Huiyi Yang, Yingshan Chen, et al.. (2020). Prussian blue nanoparticles with peroxidase-mimicking properties in a dual immunoassays for glycocholic acid. Journal of Pharmaceutical and Biomedical Analysis. 187. 113317–113317. 25 indexed citations
7.
Cui, Xiping, Natalia Vasylieva, Ding Ren Shen, et al.. (2018). Biotinylated single-chain variable fragment-based enzyme-linked immunosorbent assay for glycocholic acid. The Analyst. 143(9). 2057–2065. 18 indexed citations
8.
Cui, Xiping, Natalia Vasylieva, Bogdan Barnych, et al.. (2017). Development of an Indirect Competitive Enzyme-Linked Immunosorbent Assay for Glycocholic Acid Based on Chicken Single-Chain Variable Fragment Antibodies. Analytical Chemistry. 89(20). 11091–11097. 34 indexed citations
9.
Shen, Ding Ren, Jie Zheng, Xiping Cui, et al.. (2017). Analysis of cholyglycine acid as a biomarker for the early diagnosis of liver disease by fluorescence polarization immunoassay. Sensors and Actuators B Chemical. 256. 846–852. 31 indexed citations
10.
Tang, Huaping, Jing Yang, Ding Ren Shen, et al.. (2014). High-Throughput High-Content Imaging Assays for Identification and Characterization of Selective AXL Pathway Inhibitors. Assay and Drug Development Technologies. 12(1). 80–86. 4 indexed citations
11.
Zhu, Ying‐Jie, John B. Watson, Mengjie Chen, et al.. (2014). Integrating High-Content Analysis into a Multiplexed Screening Approach to Identify and Characterize GPCR Agonists. SLAS DISCOVERY. 19(7). 1079–1089. 10 indexed citations
12.
Tang, Huaping, Ding Ren Shen, Yong–Hae Han, et al.. (2013). Development of Novel, 384-Well High-Throughput Assay Panels for Human Drug Transporters: Drug Interaction and Safety Assessment in Support of Discovery Research. SLAS DISCOVERY. 18(9). 1072–1083. 13 indexed citations
13.
Dyckman, Alaric J., Tianle Li, Sidney Pitt, et al.. (2011). Discovery of pyrrolo[2,1-f][1,2,4]triazine C6-ketones as potent, orally active p38α MAP kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(15). 4633–4637. 9 indexed citations
14.
Wrobleski, Stephen T., Shuqun Lin, John Hynes, et al.. (2008). Synthesis and SAR of new pyrrolo[2,1-f][1,2,4]triazines as potent p38α MAP kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(8). 2739–2744. 25 indexed citations
15.
Das, Jagabandhu, Robert V. Moquin, Sidney Pitt, et al.. (2008). Pyrazolo-pyrimidines: A novel heterocyclic scaffold for potent and selective p38α inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(8). 2652–2657. 37 indexed citations
16.
Prack, M M, Janet M. Kolb, Ding Ren Shen, et al.. (2007). A High-Content Glucocorticoid Receptor Translocation Assay for Compound Mechanism-of-Action Evaluation. SLAS DISCOVERY. 12(8). 1029–1041. 18 indexed citations
17.
Wityak, John, Jagabandhu Das, Robert V. Moquin, et al.. (2003). Discovery and initial SAR of 2-amino-5-carboxamidothiazoles as inhibitors of the Src-family kinase p56Lck. Bioorganic & Medicinal Chemistry Letters. 13(22). 4007–4010. 39 indexed citations
18.
Chen, Ping, Derek Norris, Edwin J. Iwanowicz, et al.. (2002). Discovery and initial SAR of imidazoquinoxalines as inhibitors of the Src-family kinase p56Lck. Bioorganic & Medicinal Chemistry Letters. 12(10). 1361–1364. 28 indexed citations
19.
Chen, Ping, Edwin J. Iwanowicz, Derek Norris, et al.. (2002). Synthesis and SAR of novel imidazoquinoxaline-Based Lck inhibitors: improvement of cell potency. Bioorganic & Medicinal Chemistry Letters. 12(21). 3153–3156. 13 indexed citations
20.
Weksberg, Rosanna, et al.. (1993). Disruption of insulin–like growth factor 2 imprinting in Beckwith–Wiedemann syndrome. Nature Genetics. 5(2). 143–150. 334 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026